PBS Biotech
Publication

Scale Up Manufacturing Approach for Production of Human Induced Pluripotent Stem Cell-Derived Islets Using Vertical Wheel Bioreactors

Summary

This publication reports a fully suspended process for expansion and six-stage differentiation of human induced pluripotent stem cells into stem cell-derived islets in 0.1 L and 0.5 L Vertical-Wheel® Bioreactors. A fivefold increase in vessel volume produced a twelvefold increase in islet-equivalent yield without compromising islet structure. The 27-day process generated endocrine populations expressing ?-, ?-, and ?-cell markers with glucose-responsive insulin secretion and transcriptomic characteristics approaching adult islets. The study also evaluated donor-derived iPSC lines, cellular heterogeneity, off-target populations, and in vitro and in vivo function. Transplanted islets reversed diabetes in all treated mice and continued to mature after engraftment, supporting scalable SC-islet manufacturing.

This page summarizes the document. The full publication, including methods, figures and data, is available to view or download with a free account.
Access this documentSign in or create a free account to view the full publication.
Document details
DocumentPublicationCell TypeiPSC & PSC, Organoids & IsletsSystemsPBS-MiniCulture FormatAggregatesSecondary CellsStem Cell-Derived IsletsPublished2025Journalnpj Regenerative Medicine
Resources

How Can We Help?

Tell us what you need and we’ll take it from there.